Hjem › Type 2-diabetes › New Mexico
Kliniske studier for Type 2-diabetes i New Mexico
12 studier for Type 2-diabetes søker deltakere på steder i New Mexico.
Byer i New Mexico
Offisiell studietekst (engelsk)
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Albuquerque Clinical Trials Inc., Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- New Mexico Clinical Research and Osteoporosis Center, Inc., Albuquerque
- IMA Clinical Research Albuquerque, Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Albuquerque Clinical Trials, Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07754461A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Albuquerque Clinical Trials, Inc., Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Albuquerque Clinical Trials, Inc., Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07282600A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Albuquerque Clinical Trials Inc, Albuquerque
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07340320A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07662213Ketogenic Diet and Diabetes Demonstration Project
- University of New Mexico, Albuquerque
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06115265A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07662135A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Albuquerque
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07662109A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of New Mexico Hospital, Albuquerque
RekruttererFase 3
Alder 10 til 17 · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06739122DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Colorado Navajo Nation, Shiprock
RekruttererObservasjonsstudie
Alder 8 til 15 · Alle kjønn · Oppdatert 7. mai 2026 · NCT06525259Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.